Human developmental toxicity and mutagenesis

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 422, Issue 2, 1998, Pages 347-350

  Rosenkranz, Herbert S ^a   Ping Zhang, Ying ^a   Macina, Orest T ^a   Mattison, Donald R ^a   Klopman, Gilles ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Developmental toxicity; Mutagenesis; Salmonella; SAR

Indexed keywords

AMES TEST; ARTICLE; DRUG TOXICITY; GENOTOXICITY; HUMAN; MOLECULAR MODEL; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; SALMONELLA; STRUCTURE ACTIVITY RELATION;

ANIMALS; CHILD DEVELOPMENT; CHILD, PRESCHOOL; DATABASES, FACTUAL; DRUG EVALUATION, PRECLINICAL; EMBRYONIC AND FETAL DEVELOPMENT; HUMANS; MODELS, THEORETICAL; MUTAGENICITY TESTS; SALMONELLA; STRUCTURE-ACTIVITY RELATIONSHIP;

SALMONELLA;

EID: 0032481084     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(98)00170-5     Document Type: Article

References (17)

1. Ghanooni M., Mattison D.R., Zhang Y.P., Macina O.T., Rosenkranz H.S., Klopman G. Structural determinants associated with risk of human developmental toxicity. Am. J. Obstet. Gynecol. 176:1997;799-806.
2. Klopman G., Rosenkranz H.S. Prediction of carcinogenicity/mutagenicity using MULTICASE. Mutat. Res. 305:1994;33-46.
3. G.G. Briggs, R.K. Freeman, S.J. Yaffe, Drugs in Pregnancy and Lactation, 3rd ed., Williams and Wilkins, Baltimore 1990.
4. Friedman J.M., Little B.B., Brent R.L., Cordero J.F., Hanson J.W., Shepard T.H. Potential human teratogenicity of frequently prescribed drugs. Obstet. Gynecol. 75:1990;594-599.
5. Liu M., Sussman N., Klopman G., Rosenkranz H.S. Structure-activity and mechanistic relationships: the effects of chemical overlap on structural overlap in data bases of varying size and composition. Mutat. Res. 372:1996;79-85.
6. Rosenkranz H.S., Klopman G. Structural evidence for a dichotomy in rodent carcinogenesis: involvement of genetic and cellular toxicity. Mutat. Res. 303:1993;83-89.
7. E. Hodgson, P.E. Levi, A Textbook of Modern Toxicology, Elsevier, Amsterdam, 1979.
8. Bishop J.B., Witt K.L., Sloane R.A. Genetic toxicities of human teratogens. Mutat. Res. 396:1997;9-43.
9. Generoso W.M., Shourbaji A.G., Piergorsh E.W., Bishop J.B. Developmental response of zygotes exposed to similar mutagens. Mutat. Res. 250:1991;439-446.
10. Labbauf A., Klopman G., Rosenkranz H.S. Dichotomous relationship between DNA reactivity and the induction of sister chromatid exchanges in vivo and in vitro. Mutat. Res. 377:1997;37-52.
11. Rosenkranz M., Rosenkranz H.S., Klopman G. Intercellular communication, tumor promotion and non-genotoxic carcinogenesis: relationships based upon structural considerations. Mutat. Res. 381:1997;171-188.
12. Liu M., Grant S.G., Macina O.T., Klopman G., Rosenkranz H.S. Structural and mechanistic bases for the induction of mitotic chromosomal loss and duplication ('malsegregation') in the yeast Saccharomyces cerevisiae: Relevance to human carcinogenesis and developmental toxicity. Mutat. Res. 374:1997;209-231.
13. Cunningham A.R., Rosenkranz H.S., Zhang Y.P., Klopman G. Identification of 'genotoxic' and 'non-genotoxic' alerts for cancer in mice: the carcinogenicity potency data base. Mutat. Res. 398:1998;1-17.
14. J.M. Friedman, J.E. Polifka, Teratogenic Effects of Drugs: A Resource for Clinicians (TERIS), The John Hopkins University Press, Baltimore, 1994.
15. J.L. Schardein, Chemically Induced Birth Defects. Marcel Dekker, New York, 1993 .
16. Henry B., Grant S.G., Klopman G., Rosenkranz H.S. Induction of forward mutations at the thymidine kinase locus of mouse lymphoma cells: evidence for electrophilic and non-electrophilic mechanisms. Mutat. Res. 397:1998;313-335.
17. J. Gómez, O.T. Macina, D.R. Mattison, Y.P. Zhang, G. Klopman, H.S. Rosenkranz, Structural determinants of developmental toxicity in hamsters. in preparation (1998).